Vontobel Financial Products GmbH (F18299) News

"It Stops" is indeed ignorant.
The degree to which "it mitigates" may be open to discussion.

$MLGO (@.43) >>> PRIMED!!! $$$$$$$

Can-Fite Reports First Half 2024 Financial Results & Progress in Two Pivotal Phase III Clinical Studies

https://finance.yahoo.com/news/fite-reports-first-half-2024-121500188.html
Iharma Ltd.
RAMAT GAN, Israel, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NY

Approval is not the binary it once was. NWBO price depends entirely on Direct, combos, and partnerships. The MHRA decision, on its own, is not going to be the catalyst y'all are imagining.


I have often agreed with you, but I disagree with you here. You are disregarding the fac

The key word is “intended.”

I intend to be a famous Hawaiian surfer.

https://scontent-mia3-2.xx.fbcdn.net/v/t39.30808-6/457196489_822013250095581_5791809573371645625_n.jpg?_nc_cat=103&ccb=1-7&_nc_sid=127cfc&_nc_ohc=t3sLCRGBeoQQ7kNvgEYvMBC&_nc_ht=scontent-mia3-2.xx&oh=00_AYAvJkSiCKV_u_VLCAEiIpZuU_RdqvitoBvTYLUVDxpg6w&oe=66D63A5D

Key slides from Mission Hydrogen webinar on Solid Oxide Electrolyzers, yesterday at 10 am ET.

https://investorshub.advfn.com/uimage/uploads/2024/8/29/nhxin1.png

https://investorshub.advfn.com/uimage/uploads/2024/8/29/oggtb7.png

https://investorshub.advfn.

https://scontent-mia3-2.xx.fbcdn.net/v/t39.30808-6/457196489_822013250095581_5791809573371645625_n.jpg?_nc_cat=103&ccb=1-7&_nc_sid=127cfc&_nc_ohc=t3sLCRGBeoQQ7kNvgEYvMBC&_nc_ht=scontent-mia3-2.xx&oh=00_AYAvJkSiCKV_u_VLCAEiIpZuU_RdqvitoBvTYLUVDxpg6w&oe=66D63A5D

Key slides from Mission Hydrogen webinar on Solid Oxide Electrolyzers, yesterday at 10 am ET.

https://investorshub.advfn.com/uimage/uploads/2024/8/29/nhxin1.png

https://investorshub.advfn.com/uimage/uploads/2024/8/29/oggtb7.png

https://investorshub.advfn.

That's great!

$ARBB (@.27) >>> PRIMED!!! $$$$$$$

I remember when people claimed they talked to Frank and everything was great.

I remember when people claimed they talked to Alison and everything was great

I remember when CF claimed he talked the Newco and everything was great, until they realized what a 💩 fea

Green

I wouldn't put it all on him. He was the only one that questioned Dave and looked for the truth. Because truth be told, Dave has NOT been very honest to his shareholders. Yes, he is doing well getting the company going but it's been at our expense. Alot of dilution and converted shares which he

The industry is not looking for legacy solutions longer term since they know these solutions belong to a sunset industry.
EVERYBODY knows that polymers are the future since polymers are scalable.

L_R

You have to account for the conversion ratio. That puts the market cap between $35-36 mil.

If you've followed Charlie Fernandez the last few years, he has a track record of rewarding himself, other directors and the Board with nice stock bonuses when they make deals. I expect the mar

I could believe it but it this instance the picture says SATIRE Nothing on this page is real.

Outstanding Shares Updated:
- 🔴 From: 1,428,337,574 (1.43B - 6/14/2024)
- 🟢 To: 1,471,954,105 (1.47B - 8/16/2024)
(Diff: 43.62M, % Change: 3.054%)
2:57 AM · Aug 29, 2024
·
88
Views

You've got me very curious on the other one....

Always a good approach. Keep some skin in the game. Were you able to sell a lot of those at 2?

https://x.com/OTCMTracker/status/1829050710446534846

Personally, I don’t think a lot of these price prediction downgrades will age well. This is ultimately intended to be a universal cancer vaccine, and it’s almost certainly about to get its proverbial foot in the door via maa approval, and if you price prediction bashers don’t think that makes NWBO

Large buying volume is pouring into NVDA, in the last few minutes.

The FACT of the matter is that NVDA BEAT ESTIMATES. Some very foolish "investors" sold, because they didn't like the fact that NVDA didn't beat estimates by the gazillion percent they THOUGHT it should beat them by. And it drove down the share price. So far, it's been ONE DAY of down share prices

Peter Davis
@peter_brit
·
2h
#dcvax $nwbo #gbm

Two more Keytruda Phase 3 failures from Merck..

Merck Provides Update on Phase 3 KEYNOTE-867 and KEYNOTE-630 Trials

https://merck.com/news/merck-provides-update-on-phase-3-keynote

Once trading app is available, this can hit $1 range.

https://chaintrade.ai/
A Smarter Way to Trade and Invest
Advanced AI Solutions
AI is revolutionizing trading and investing by leveraging massive datasets to uncover insights and predict market trends and hid